Medidata

The third case of this grade in the index alongside Elation and Waystar, and descriptive rather than critical. What a sponsor buys is the clinical trial platform, anchored by Rave EDC across more than 38,000 trials; the AI capabilities are woven into that platform and accelerate work inside it. The company's own framing, that it weaves intelligence into more solutions across a unified platform, correctly places the AI as a layer. No sponsor selects Medidata for the AI alone, which is precisely the comparison a buyer needs against a specialist such as Saama or Deep 6.

Deployment scale is exceptional and long standing, with the AI reported across more than 500 clinical studies over a decade and more than 120 AI supported studies starting in 2025, against a platform footprint of 38,000 trials and 12 million patients. Named customer Eisai reports up to 80 percent faster data review with Clinical Data Studio, and the imaging capability reports 32 percent faster PHI redaction. Held back from A because the figures are customer or vendor stated without published methodology, and the platform's scale should not be read as evidence for the newer AI capabilities specifically, which is the same distinction applied to Medable.

Health Record Connect is the strongest element here and solves a real problem: it uses FHIR and health information exchanges to pull existing patient health records directly into trial data capture, so sites complete Rave EDC forms from the chart rather than re keying. Clinical Data Studio separately integrates non Medidata sources including third party labs and other electronic data capture systems, which matters because sponsors rarely run a single vendor stack.

No public pricing. Contact the vendor. Enterprise agreements with sponsors, typically scoped by study count and module. As with other platform vendors indexed under the scope rule, buyers should establish whether AI capabilities carry incremental cost or are included in platform licensing, since that determines the comparison against a separately priced specialist.

Clearly bounded to sponsor side clinical development for biopharmaceutical and medtech customers, spanning study build, data capture, data quality management, imaging, and patient facing capture. No claims outside clinical research.